Crystal structure of the human glucose transporter GLUT1
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 Å resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Briefly, the U-shaped intracellular helical bundle of GLUT1 is formed by three helixes and functions as a latch to secure GLUT1 in the outward open conformation making the sugar binding site accessible extracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 has a single binding site that can be accessed by glucose (and other hexoses) from either side of the luminal and/or abluminal endothelial membrane extracellularly or intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 is expressed in endothelial cells, but not in neurons (141, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“After binding to the extracellular binding site, glucose enters GLUT1, which leads to a conformational change causing extracellular transmembrane domains 1, 4, and 7 to function as a latch to secure the inward open conformation of GLUT1 enabling release of glucose intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Sequence and Structure of a Human Glucose Transporter
Mueckler, M., Caruso, C., Baldwin, S. A., Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., & Lodish, H. F. (1985) · Science · doi:10.1126/science.3839598 · Cited by 1,547
Simple Allosteric Model for Membrane Pumps
JARDETZKY, O. (1966) · Nature · doi:10.1038/211969a0 · Cited by 1,291
Research works printed but not linked: 1
- Mitchell, P. David Keilin’s respiratory chain concept and its chemiosmotic consequences. In Nobel Lectures, Chemistry 1971–1980 (ed. Forsén, S. ) (World Scientific Publishing Co., 1978)
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
A Call for Systematic Research on Solute Carriers
César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., Reithmeier, R. A., Hepworth, D., Hediger, M. A., Edwards, A. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.022 · Cited by 580
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Ancey, P., Contat, C., & Meylan, E. (2018) · The FEBS Journal · doi:10.1111/febs.14577 · Cited by 514
Shared Molecular Mechanisms of Membrane Transporters
Drew, D., & Boudker, O. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014520 · Cited by 506
Chen, L.-Q., Cheung, L. S., Feng, L., Tanner, W., & Frommer, W. B. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033904 · Cited by 507
“On the basis of a comparison between the outward-facing structure of XylE and the inward-open one of GLUT1, Yan and collaborators (94) proposed a translocation mechanism in which the C-terminal domain recognizes glucose while the N-terminal domain undergoes a rocking-type movement that exposes the substrate to alterna…”
BackgroundStructures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
Understanding transport by the major facilitator superfamily (MFS): structures pave the way
Quistgaard, E. M., Löw, C., Guettou, F., & Nordlund, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.25 · Cited by 458
Structural Biology of the Major Facilitator Superfamily Transporters
Yan, N. (2015) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-060414-033901 · Cited by 450
Self-citationA guide to plasma membrane solute carrier proteins
Pizzagalli, M. D., Bensimon, A., & Superti‐Furga, G. (2021) · The FEBS Journal · doi:10.1111/febs.15531 · Cited by 379
Molecular basis of ligand recognition and transport by glucose transporters
Deng, D., Sun, P., Yan, C., Ke, M., Jiang, X., Xiong, L., Ren, W., Hirata, K., Yamamoto, M., Fan, S., et al. (2015) · Nature · doi:10.1038/nature14655 · Cited by 384
Self-citationZhang, R., Qin, X., Kong, F., Chen, P., & Pan, G. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1582730 · Cited by 363
“C4- glucose related interaction (Deng et al., 2014).”
A Glimpse of Structural Biology through X-Ray Crystallography
Shi, Y. (2014) · Cell · doi:10.1016/j.cell.2014.10.051 · Cited by 365
“Crystal structure of the human glucose transporter GLUT1—the first eukaryotic MFS structure—allows rationalization of disease-derived mutations (Deng et al., 2014).”
BackgroundGlucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
“2 Å resolution has been determined with the protein in an inward-open conformation (PDB 4PYP) [44].”
BackgroundInfluentialLipid–Protein Interactions Are Unique Fingerprints for Membrane Proteins
Corradi, V., Mendez-Villuendas, E., Ingólfsson, H. I., Gu, R.-X., Siuda, I., Melo, M. N., Moussatova, A., DeGagné, L. J., Sejdiu, B. I., Singh, G., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00143 · Cited by 358
Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
Wang, N., Jiang, X., Zhang, S., Zhu, A., Yuan, Y., Xu, H., Lei, J., & Yan, C. (2021) · Cell · doi:10.1016/j.cell.2020.11.043 · Cited by 340
Self-citationPathways of arsenic uptake and efflux
Garbinski, L. D., Rosen, B. P., & Chen, J. (2019) · Environment International · doi:10.1016/j.envint.2019.02.058 · Cited by 335
“The x-ray crystal structure of GLUT1 has been solved (Deng et al., 2014) (Figure 1), however the mechanism of As(III) transport cannot be deduced from the glucose translocation pathway.”
BackgroundGLUT4 Mobilization Supports Energetic Demands of Active Synapses
Ashrafi, G., Wu, Z., Farrell, R. J., & Ryan, T. A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.020 · Cited by 326
“See also Figure S4. in an inward-facing conformation (Deng et al., 2014).”
Pathways of Arsenic Uptake and Efflux
(2012) · Current Topics in Membranes · doi:10.1016/b978-0-12-394390-3.00012-4 · Cited by 301
Cell permeability beyond the rule of 5
Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 297
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 261
Carbonic Anhydrases: Role in pH Control and Cancer
Mboge, M., Mahon, B., McKenna, R., & Frost, S. (2018) · Metabolites · doi:10.3390/metabo8010019 · Cited by 281
“For modeling of MCT and GLUT1, PDBs 1PW4 [123] and 4PYP [124] were used, respectively.”
MethodGlucose Transporters in Cardiac Metabolism and Hypertrophy
Shao, D., & Tian, R. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c150016 · Cited by 243
“reported the crystal structure of human GLUT1 in 2014 (35).”
GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters
Deng, D., & Yan, N. (2016) · Protein Science · doi:10.1002/pro.2858 · Cited by 275
“The structure of human GLUT1 was eventually reported in 2014.(14) The domain organization of GLUT1, which was captured in an inward-open con-”
BackgroundSelf-citationDeBosch, B. J., Heitmeier, M. R., Mayer, A. L., Higgins, C. B., Crowley, J. R., Kraft, T. E., Chi, M., Newberry, E. P., Chen, Z., Finck, B. N., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aac5472 · Cited by 280
“In both SLC2A1 and SLC2A8, residues 257 to 281 .”
InfluentialPochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00061 · Cited by 249
Structure and mechanism of the mammalian fructose transporter GLUT5
Nomura, N., Verdon, G., Kang, H. J., Shimamura, T., Nomura, Y., Sonoda, Y., Hussien, S. A., Qureshi, A. A., Coincon, M., Sato, Y., et al. (2015) · Nature · doi:10.1038/nature14909 · Cited by 239
Structure, function and regulation of mammalian glucose transporters of the SLC2 family
Holman, G. D. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02411-3 · Cited by 225
Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin
Waldhart, A. N., Dykstra, H., Peck, A. S., Boguslawski, E. A., Madaj, Z. B., Wen, J., Veldkamp, K., Hollowell, M., Zheng, B., Cantley, L. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.041 · Cited by 242
“…uthor M anuscript A uthor M anuscript TXNIP Regulation of GLUT4 Because all class I glucose facilitative transporters have a high sequence homology (Deng et al., 2014), and given that TXNIP can interact with GLUT1, it would not be surprising if TXNIP can also interact with other class I members.”
BackgroundLei, S., Zhang, J., Blum, N. T., Li, M., Zhang, D.-Y., Yin, W., Zhao, F., Lin, J., & Huang, P. (2022) · Nature Communications · doi:10.1038/s41467-022-29082-1 · Cited by 220
Kapoor, K., Finer-Moore, J. S., Pedersen, B. P., Caboni, L., Waight, A., Hillig, R. C., Bringmann, P., Heisler, I., Müller, T., Siebeneicher, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603735113 · Cited by 213
“The structures were solved by molecular replacement in PHENIX (28) using hGLUT1 Protein Data Bank (PDB) ID code 4PYP as the search model (13).”
BackgroundMethodInfluentialGlut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Zambrano, A., Molt, M., Uribe, E., & Salas, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133374 · Cited by 210
“TM7b leans towards the core of the cavity, and TM10b moves away from the transport path while the substrate is released [58].”
BackgroundA Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Wang, J., Ye, C., Chen, C., Xiong, H., Xie, B., Zhou, J., Chen, Y., Zheng, S., & Wang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15171 · Cited by 205
SLC transporters: structure, function, and drug discovery
Colas, C., Ung, P. M.-U., & Schlessinger, A. (2016) · MedChemComm · doi:10.1039/c6md00005c · Cited by 202
Hladky, S. B., & Barrand, M. A. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0113-6 · Cited by 206
Andersen, J., He, G.-X., Kakarla, P., KC, R., Kumar, S., Lakra, W., Mukherjee, M., Ranaweera, I., Shrestha, U., Tran, T., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120201487 · Cited by 167
“sapiens [263].”
Structures of bacterial homologues of SWEET transporters in two distinct conformations
Xu, Y., Tao, Y., Cheung, L. S., Fan, C., Chen, L.-Q., Xu, S., Perry, K., Frommer, W. B., & Feng, L. (2014) · Nature · doi:10.1038/nature13670 · Cited by 167
Wei, R., Mao, L., Xu, P., Zheng, X., Hackman, R. M., Mackenzie, G. G., & Wang, Y. (2018) · Food & Function · doi:10.1039/c8fo01397g · Cited by 172
“24 Given that HIF1 α and GLUT1 are critical players in regulating glucose metabolism, we then explored whether EGCG could a ff ect its expression levels.”
Structural biology of solute carrier (SLC) membrane transport proteins
Bai, X., Moraes, T. F., & Reithmeier, R. A. F. (2017) · Molecular Membrane Biology · doi:10.1080/09687688.2018.1448123 · Cited by 175
“The inward-open GLUT1 gate is dominated by a cluster of hydrogen bonds formed by residues from TM1 and 7 (Deng et al., 2014).”
BackgroundInfluentialBlood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 184
“Glucose, which is the key energy metabolite in the CNS, is transported into the brain via a concentration gradient by carbohydrate transporters, most prominently, glucose transporter-1 (GLUT1) [84, 85].”
BackgroundAutophagy induction by trehalose: Molecular mechanisms and therapeutic impacts
Hosseinpour‐Moghaddam, K., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26583 · Cited by 168
“…acids involved in trehalose binding shows the highly conserved residues Gln162, Gln267, Gln268, Asn273, Gly390, and Asn417, which highly constitute hydrogen bond network at the glucose binding site (Deng et al., 2014), to form polar interactions between the ligand and GLUT8 (Mayer et al., 2016).”
BackgroundGLUT1 regulates cell glycolysis and proliferation in prostate cancer
Xiao, H., Wang, J., Yan, W., Cui, Y., Chen, Z., Gao, X., Wen, X., & Chen, J. (2018) · The Prostate · doi:10.1002/pros.23448 · Cited by 167
“Glucose transporter 1 (GLUT1) is a member of the glucose transporter family and regulates glucose transport across the cell membrane.(7) Glucose transmembrane transport is not only the ratelimiting step of glycolysis but also the first step of glucose metabolism.”
BackgroundStructure, mechanism and cooperation of bacterial multidrug transporters
Du, D., van Veen, H. W., Murakami, S., Pos, K. M., & Luisi, B. F. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.07.015 · Cited by 162
Pseudo Natural Products—Chemical Evolution of Natural Product Structure
Karageorgis, G., Foley, D. J., Laraia, L., Brakmann, S., & Waldmann, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202016575 · Cited by 160
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
Proton-coupled sugar transport in the prototypical major facilitator superfamily protein XylE
Wisedchaisri, G., Park, M.-S., Iadanza, M. G., Zheng, H., & Gonen, T. (2014) · Nature Communications · doi:10.1038/ncomms5521 · Cited by 174
Lee, E. E., Ma, J., Sacharidou, A., Mi, W., Salato, V. K., Nguyen, N. X., Jiang, Y., Pascual, J. M., North, P. E., Shaul, P. W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.015 · Cited by 154
“For example, the R223 residue participates in hydrogen bond interactions that stabilize the transporter’s inward open configuration (Deng et al., 2014), so mutations at this site might also alter the intrinsic properties of the transporter.”
BackgroundInfluentialReceptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
Haqqani, A. S., Bélanger, K., & Stanimirovic, D. B. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1360302 · Cited by 153
Regulation of Amino Acid Transport in Saccharomyces cerevisiae
Bianchi, F., Klooster, J. S. V. ’., Ruiz, S. J., & Poolman, B. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00024-19 · Cited by 157
“Members of the sugar porter subfamily, including the human glucose transporter GLUT1 (218) and the E.”
BackgroundPatra, M., Awuah, S. G., & Lippard, S. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06937 · Cited by 145
Zhang, T., Ouyang, H., Mei, X., Lü, B., Yu, Z., Chen, K., Wang, Z., & Ji, L. (2019) · The FASEB Journal · doi:10.1096/fj.201802614rrr · Cited by 150
Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies
Møller, R. S., Larsen, L. H. G., Johannesen, K. M., Talvik, I., Talvik, T., Vaher, U., Miranda, M. J., Farooq, M., Nielsen, J. E. K., Svendsen, L. L., et al. (2016) · Molecular Syndromology · doi:10.1159/000448369 · Cited by 146
Direct protein-lipid interactions shape the conformational landscape of secondary transporters
Martens, C., Shekhar, M., Borysik, A. J., Lau, A. M., Reading, E., Tajkhorshid, E., Booth, P. J., & Politis, A. (2018) · Nature Communications · doi:10.1038/s41467-018-06704-1 · Cited by 134
Zhou, L., Wang, Y., Zhou, M., Zhang, Y., Wang, P., Li, X., Yang, J., Wang, H., & Ding, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03914-5 · Cited by 147
“Fanconi anemia pathway (16) AMPK signaling pathway (30) TNF signaling pathway (40) NF-kappa B signaling pathway (37) Osteoclast differentiation (40) B cell receptor signaling pathway (25) Melanoma (23) HIF-1 signaling pathway (32) p53 signaling pathway (22) mTOR signaling pathway (23) Spliceosome (36) Legionellosis (3…”
The genetic landscape of the human solute carrier (SLC) transporter superfamily
Schaller, L., & Lauschke, V. M. (2019) · Human Genetics · doi:10.1007/s00439-019-02081-x · Cited by 133
Stress habituation, body shape and cardiovascular mortality
Peters, A., & McEwen, B. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.001 · Cited by 148
Gating Topology of the Proton-Coupled Oligopeptide Symporters
Fowler, P. W., Orwick‐Rydmark, M., Radestock, S., Solcan, N., Dijkman, P. M., Lyons, J. A., Kwok, J., Caffrey, M., Watts, A. G., Forrest, L. R., et al. (2015) · Structure · doi:10.1016/j.str.2014.12.012 · Cited by 133
“…al., 2002; Abramson et al., 2003; Huang et al., 2003; Yin et al., 2006; Dang et al., 2010; Newstead et al., 2011; Solcan et al., 2012; Sun et al., 2012; Yan et al., 2013; Pedersen et al., 2013; Quistgaard et al., 2013; Guettou et al., 2013; Doki et al., 2013; Jiang et al., 2013; Deng et al., 2014).”
BackgroundMnO2 Motor: A Prospective Cancer-Starving Therapy Promoter
Zhang, Y., Qiu, W., Zhang, M., Zhang, L., & Zhang, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b01818 · Cited by 131
Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 131
“Glucose and other hexose/pentose sugars recognized by GLUT [73,74]”
BackgroundRevisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 131
Liu, Y., Wang, F., Peng, D., Zhang, D., Liu, L., Wei, J., Yuan, J., Zhao, L., Jiang, H., Zhang, T., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk7399 · Cited by 134
“A previous study indicated that GLUT1 transport of glucose depends on the completion of a full transport cycle: “outward-open, ligand-bound and occluded, inward-open, and ligand-free and occluded,” where glucose shows high binding affinity for the outward-open and ligand-bound structures ( 37 ).”
BackgroundSelf-citationDevelopments in Carbohydrate-Based Cancer Therapeutics
Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 134
“No prodrug co-crystalized with human GLUT-1 is known due to rapid interchangeable conformations, which impede crystallization [49].”
BackgroundCerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy
Mayer, A. L., Higgins, C. B., Heitmeier, M. R., Kraft, T. E., Qian, X., Crowley, J. R., Hyrc, K. L., Beatty, W. L., Yarasheski, K. E., Hruz, P. W., et al. (2016) · Scientific Reports · doi:10.1038/srep38586 · Cited by 125
The physiological role of drug transporters
Liang, Y., Li, S., & Chen, L. (2015) · Protein & Cell · doi:10.1007/s13238-015-0148-2 · Cited by 130
“For example, genetic defects in glucose transporters like GLUT1 (SLC2A1) have been associated with glucose-galactose malabsorption (Pascual et al., 2004).”
BackgroundInfluentialChen, X., Yu, J., Tian, H., Shan, Z., Liu, W., Pan, Z., & Ren, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28692 · Cited by 122
“As is widely recognized, glucose transmembrane transport could be regulated by GLUT1 (Deng et al., 2014).”
BackgroundSchulz, J., Hartz, A. M. S., & Bauer, B. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000025 · Cited by 122
“These transporters belong to the solute carrier superfamily and are either facilitative, secondary, or tertiary active transporters (Deng et al., 2014; Morris et al., 2017; Yan et al., 2019b).”
BackgroundTan, P. K., Liu, S., Gunić, E., & Miner, J. N. (2017) · Scientific Reports · doi:10.1038/s41598-017-00706-7 · Cited by 115
The Druggability of Solute Carriers
Wang, W., Gallo, L. H., Jadhav, A. M., Hawkins, R., & Parker, C. G. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01237 · Cited by 115
Mechanism of Substrate Translocation in an Alternating Access Transporter
Latorraca, N. R., Fastman, N. M., Venkatakrishnan, A., Frommer, W. B., Dror, R. O., & Feng, L. (2017) · Cell · doi:10.1016/j.cell.2017.03.010 · Cited by 112
“102 Cell 169, 96–107, March 23, 2017 sugar transporter structures, in which multiple residues appear to directly coordinate with substrate (Cao et al., 2011; Deng et al., 2014; Faham et al., 2008; Kumar et al., 2014; Oldham et al., 2007), SemiSWEET appears to form fewer direct hydrogen bonds with glucose in this outwa…”
The recombinant expression systems for structure determination of eukaryotic membrane proteins
He, Y., Wang, K., & Yan, N. (2014) · Protein & Cell · doi:10.1007/s13238-014-0086-4 · Cited by 133
“Thus, mutating of glycosylation sites or deglycosylation by enzymes is an essential step for crystallization (Deng et al., 2014).”
BackgroundSelf-citationStructures of human ENT1 in complex with adenosine reuptake inhibitors
Wright, N. A., & Lee, S. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0245-7 · Cited by 109
Ojelabi, O., Lloyd, K. P., Simon, A. H., Zutter, J. K. D., & Carruthers, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759175 · Cited by 108
Structure and mechanism of blood–brain-barrier lipid transporter MFSD2A
Wood, C. A. P., Zhang, J., Aydın, D., Xu, Y., Andreone, B. J., Langen, U. H., Dror, R. O., Gu, C., & Feng, L. (2021) · Nature · doi:10.1038/s41586-021-03782-y · Cited by 112
Antiviral Activity of Carrageenans and Processing Implications
Álvarez-Viñas, M., Souto, S., Flórez-Fernández, N., Torres, M. D., Bandín, I., & Domínguez, H. (2021) · Marine Drugs · doi:10.3390/md19080437 · Cited by 109
“Deng and co-authors designed a sugar-free healthcare candy with antibacterial and antiviral effects, prepared with plant extracts, fruits, sweeteners and gelatin, carrageenan, and pectin [127].”
BackgroundMa, J., Wang, Q., Huang, Z., Yang, X., Nie, Q., Hao, W., Wang, P. G., & Wang, X. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00433 · Cited by 107
Molecular mechanism of substrate recognition and transport by the AtSWEET13 sugar transporter
Han, L., Zhu, Y., Liu, M., Zhou, Y., Lu, G., Lan, L., Wang, X., Zhao, Y., & Zhang, X. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1709241114 · Cited by 102
“Currently, sugar transporters are mainly classified into three superfamilies: the major facilitator superfamily (MFS), such as glucose transporters (GLUTs) (8, 9); the sodium solute symporter family (SSF), such as sodium-glucose cotransporters (SGLTs) (10); and Sugar Will Eventually be Exported Transporter (SWEET) pro…”
BackgroundNew insights into GluT1 mechanics during glucose transfer
Galochkina, T. V., Chong, M. N. F., Challali, L., Abbar, S., & Etchebest, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37367-z · Cited by 102
Yu, X., Yang, G., Yan, C., Baylon, J. L., Jiang, J., He, F., Lu, G., Hasegawa, K., Okumura, H., Wang, T., et al. (2017) · Cell Research · doi:10.1038/cr.2017.83 · Cited by 101
Self-citationTumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy
Zhang, M., Li, C., Wang, S., Liu, T., Song, X., Yang, X., Feng, J. X., & Zhang, X. (2018) · Small · doi:10.1002/smll.201803602 · Cited by 103
Paulsen, P. A., Custódio, T. F., & Pedersen, B. P. (2019) · Nature Communications · doi:10.1038/s41467-018-08176-9 · Cited by 103
The ins and outs of vesicular monoamine transporters
Yaffe, D., Forrest, L. R., & Schuldiner, S. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201711980 · Cited by 96
“Currently, the glucose (GLUT1/3) and fructose (GLUT5) transporter are the only mammalian MFS transporters for which structures have been reported (Deng et al., 2014, 2015; Nomura et al., 2015).”
BackgroundZhang, H., Hassan, Y. I., Renaud, J. B., Liu, R., Yang, C., Sun, Y., & Tsao, R. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600928 · Cited by 101
The role of SLC transporters for brain health and disease
Nguyen, Y. T.-K., Ha, H. T. T., Nguyen, T. H., & Nguyen, L. N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04074-4 · Cited by 102
“The recent crystalized structures of GLUTs have provided the mechanistic basis of how glucose is transported across membranes of neural cells [22, 23].”
BackgroundAn update on therapeutic opportunities offered by cancer glycolytic metabolism
Granchi, C., Fancelli, D., & Minutolo, F. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.041 · Cited by 111
Targeting SLC transporters: small molecules as modulators and therapeutic opportunities
Schlessinger, A., Zatorski, N., Hutchinson, K., & Colas, C. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.05.011 · Cited by 94
Wang, C., Bao, X., Li, Y., Jiao, C., Hou, J., Zhang, Q., Zhang, W., Liu, W., & Shen, Y. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.04.007 · Cited by 101
Cryo-EM structure of human glucose transporter GLUT4
Yuan, Y., Kong, F., Xu, H., Zhu, A., Yan, N., & Yan, C. (2022) · Nature Communications · doi:10.1038/s41467-022-30235-5 · Cited by 100
Self-citationHighlighting membrane protein structure and function: A celebration of the Protein Data Bank
Li, F., Egea, P. F., Vecchio, A. J., Asial, I., Gupta, M., Paulino, J., Bajaj, R., Dickinson, M. S., Ferguson-Miller, S. M., Monk, B. C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100557 · Cited by 98
Hong, L., Zeng, J., Xie, R., Schulz, M. J., Tedesco, R., Qu, J., Erhard, K. F., Mack, J. F., Raha, K., Rendina, A. R., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00214 · Cited by 89
Mechanistic insights into GLUT1 activation and clustering revealed by super-resolution imaging
Yan, Q., Lu, Y., Zhou, L., Chen, J., Xu, H., Cai, M., Shi, Y. C., Jiang, J., Xiong, W., Gao, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803859115 · Cited by 89
“Many researchers have been attracted to focus on its vital physiological and pathophysiological sense (7, 8), and its overexpression has become an important hypoxic marker in malignant tumors and a prognostic indicator for tumorigenesis (7, 9).”
BackgroundXia, J., Zhang, S., Zhang, R., Wang, A., Zhu, Y., Dong, M., Ma, S., Hong, C., Liu, S., Wang, D., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01623-2 · Cited by 91
“In addition, Q282 and Q283 were proved as key residues for glucose-Glut1 binding [39].”
BackgroundTumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening
Zhao, J., Liu, Y., Zhu, L., Li, J., Liu, Y., Luo, J., Xie, T., & Chen, D. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.04.015 · Cited by 89
Structural basis for the facilitative diffusion mechanism by SemiSWEET transporter
Lee, Y., Nishizawa, T., Yamashita, K., Ishitani, R., & Nureki, O. (2015) · Nature Communications · doi:10.1038/ncomms7112 · Cited by 89
“As compared with other sugar transporters, such as human GLUT1, in which five residues are involved in hydrogen-bonding interactions with glucose 9 , EcSemiSWEET probably has fewer hydrophilic residues for substrate binding, consistent with its low-affinity transport in the liposome assay (Fig.”
Jordan, P., Choe, J., Boles, E., & Oreb, M. (2016) · Scientific Reports · doi:10.1038/srep23502 · Cited by 89
Tilekar, K. N., Upadhyay, N., Iancu, C. V., Pokrovsky, V. S., Choe, J., & Ramaa, C. S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188457 · Cited by 95
Zhao, R., Aluri, S., & Goldman, I. D. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.002 · Cited by 89
“Modeling the tertiary structure of PCFT At the present time only a few crystallographic structures of eukaryotic solute carriers have been obtained (Coleman et al., 2016; Deng et al., 2014, 2015; Nomura et al., 2015; Pedersen et al., 2013; Penmatsa et al., 2013).”
Background
Metadata
- Authors
- Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N.
- Affiliations
- Center for Life Sciences (CN)
- Tsinghua University (CN)
- Corresponding author
- Yan, Nieng
- Venue
- Nature
- Published
- 2014-05-18
- Volume
- 510
- Issue
- 7503
- Pages
- 121-125
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987612677
- Cited by
- 777
- References
- 62
- Citations by year
- 2026: 50 · 2025: 64 · 2024: 64 · 2023: 52 · 2022: 72 · 2021: 73 · 2020: 70 · 2019: 59 · 2018: 64 · 2017: 67 · 2016: 57 · 2015: 65 · 2014: 19
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- GLUT1, glucose transporters, crystal structure, major facilitator superfamily, inward-open conformation, GLUT1 deficiency syndrome, disease-associated mutations, alternating access mechanism, XylE, proton-coupled transport, anticancer drug targets
- MeSH terms
- Carbohydrate Metabolism, Inborn Errors, Humans, Ligands, Models, Biological, Models, Molecular, Monosaccharide Transport Proteins, Mutation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, Symporters, Escherichia coli Proteins, Glucose Transporter Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.